Package Leaflet: Information for the Patient
Lacosamida Jubilant 50 mgfilm-coated tablets EFG
Lacosamida Jubilant 100 mgfilm-coated tablets EFG
Lacosamida Jubilant 150 mgfilm-coated tablets EFG
Lacosamida Jubilant 200 mgfilm-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
What is Lacosamida
This medicine contains lacosamida, which belongs to a group of medicines called
“antiepileptic medicines”. These medicines are used to treat epilepsy.
What is Lacosamida used for
Generalized seizures affect both sides of the brain. However, they can then spread to larger areas on both sides of the brain.
Do not takeLacosamida Jubilant
Do not take this medicine if any of the above applies to you. If you are not sure, consult your doctor or pharmacist before taking this medicine.
Warnings and precautions
Consult your doctor before starting to use Lacosamida Jubilant if:
If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking Lacosamida Jubilant.
Children
Lacosamida is not recommended in children under 4 years of age. This is because it is not yet known if it is effective and safe for children in this age group.
Other medicines andLacosamida Jubilant
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines that affect the heart, as Lacosamida may also affect the heart:
Tell your doctor or pharmacist if you are taking any of the following medicines, as they may also increase or decrease the effect of Lacosamida in your body:
If any of the above applies to you (or you are not sure) talk to your doctor or pharmacist before taking Lacosamida Jubilant.
TakingLacosamida Jubilantwith alcohol
As a precaution, do not take this medicine with alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Lacosamida is not recommended if you are pregnant or breastfeeding, as the effects of this medicine on pregnancy and the fetus or newborn are not known. Additionally, it is not known if Lacosamida passes into breast milk. Ask your doctor for advice immediately if you are pregnant or plan to become pregnant. Your doctor will help you decide whether to take Lacosamida or not.
Do not stop treatment without talking to your doctor first, as this may increase the risk of seizures (fits). Worsening of your condition may also harm the fetus.
Driving and using machines
Do not drive, ride a bike, or use any tools or machines until you know if this medicine affects you. The reason is that Lacosamida Jubilant may cause dizziness or blurred vision.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking Lacosamida
Normally, you will start by taking a low dose each day and your doctor will gradually increase the dose over several weeks. When you reach the dose that works well for you, called the “maintenance dose”, you will take the same amount each day. Lacosamida is used as long-term treatment. You will need to continue taking lacosamida until your doctor tells you to stop.
How much to take
The following are the usual recommended doses of lacosamida for different age and weight groups. Your doctor may prescribe a different dose if you have kidney or liver problems.
Use in adults, adolescents, and children from 4 years of age who weigh 50 kg or more.When taking lacosamida alone:
The usual starting dose is 50 mg twice a day.
Your doctor may also prescribe a starting dose of 100 mg of lacosamida twice a day. Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 300 mg twice a day.
When taking lacosamida with other antiepileptic medicines:
The usual starting dose is 50 mg twice a day.
Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 200 mg twice a day.
If you weigh 50 kg or more, your doctor may start lacosamida treatment with a single “loading dose” of 200 mg. Then you will start taking the continuous maintenance dose 12 hours later.
Children and adolescents who weigh less than 50 kg
The dose depends on body weight. Treatment is usually started with the oral solution and only changed to tablets if the patient is able to take them and get the correct dose with tablets of different strengths. The doctor will prescribe the pharmaceutical form that best suits you.
If you take more Lacosamida than you should
If you have taken more lacosamida than you should, talk to your doctor immediately. Do not attempt to drive.
You may experience:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Lacosamida
If you have forgotten to take a dose after 6 hours after the scheduled dose, do not take the missed dose. Instead, take lacosamida the next time you would normally take it.
If you stop taking Lacosamida
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, lacosamida can cause side effects, although not everybody gets them.
Side effects on the nervous system, such as dizziness, may be greater after a single “loading dose”.
Tell your doctor or pharmacist if you get any of the following side effects:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
decreased sensitivity, difficulty articulating words, attention problems;
Uncommon: may affect up to 1 in 100 people
exaggerated feeling of well-being, seeing and/or hearing things that are not real;
thoughts of self-harm or suicide or attempted suicide: tell your doctor immediately;
passing out.
Frequency not known: cannot be estimated from the available data
severe skin reaction, which may include high temperature and other flu-like symptoms, rash on the face, generalized rash with swollen lymph nodes (lymph nodes enlarged). Blood tests may show increased liver enzyme levels and an increase in a type of white blood cell (eosinophilia);
seizures.
Other side effects in children
Common: may affect up to 1 in 10 children
Uncommon: may affect up to 1 in 100 children
Frequency not known: cannot be estimated from the available data
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition ofLacosamida Jubilant
The active ingredient is lacosamida.
Each film-coated tablet contains 50 mg lacosamida.
Each film-coated tablet contains 100 mg lacosamida.
Each film-coated tablet contains 150 mg lacosamida.
Each film-coated tablet contains 200 mg lacosamida.
The other components are:
Tablet core: microcrystalline cellulose, crospovidone, hypromellose (low substituted), hypromellose, silicified microcrystalline cellulose (colloidal anhydrous silica and microcrystalline cellulose), magnesium stearate.
Film coating: polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide (E171), colorants*.
50 mg tablets: red iron oxide (E172), black iron oxide (E172), aluminum lake indigo carmine (E132).
100 mg tablets: yellow iron oxide (E172).
150 mg tablets: red iron oxide (E172), black iron oxide (E172), yellow iron oxide (E172).
200 mg tablets: aluminum lake indigo carmine (E132).
Appearance ofLacosamida Jubilantand container content
Lacosamida Jubilant is available in packs of 12, 14, 24, 28, 36, 48, 56, 60, 72, 84, 96, 120, 168 (pack of 168 only for 50 mg and 100 mg), 14 x 1 and 56 x 1 film-coated tablets, and in a multipack of 3 packs, each containing 56 film-coated tablets (multipack only for 150 mg and 200 mg). The pack of 14 x 1 or 56 x 1 tablets is available in precut unit-dose PVC/PVDC blisters sealed with an aluminum foil, all other packs are available in standard PVC/PVDC blisters sealed with an aluminum foil.
Only some pack sizes may be marketed.
Marketing authorization holder;
Jubilant Pharmaceuticals nv.
Axxes Business Park.
Guldensporenpark 22 - Block C.
9820 Merelbeke.
Belgium.
Manufacturer:
PSI supply nv.
Axxes Business Park.
Guldensporenpark 22, Block C.
Merelbeke, Belgium.
Or.
PharmaS d.o.o.
Industrijska Cesta 5, Potok, Popovaca.
Sisacko-Moslavacka, 44317, Croatia.
This medicinal product is authorized in the EEA Member States under the following names:
Germany | Lacosamid Jubilant 50 mg film-coated tablets. Lacosamid Jubilant 100 mg film-coated tablets. Lacosamid Jubilant 150 mg film-coated tablets. Lacosamid Jubilant 200 mg film-coated tablets. |
Portugal | Lacosamida Jubilant 50 mg film-coated tablets. Lacosamida Jubilant 100 mg film-coated tablets. Lacosamida Jubilant 150 mg film-coated tablets. Lacosamida Jubilant 200 mg film-coated tablets. |
Spain | Lacosamida Jubilant 50 mg film-coated tablets EFG. Lacosamida Jubilant 100 mg film-coated tablets EFG. Lacosamida Jubilant 150 mg film-coated tablets EFG. Lacosamida Jubilant 200 mg film-coated tablets EFG. |
Date of last revision of this leafletJune 2021.
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.